Can population differences in chemotherapy outcomes be inferred from differences in pharmacogenetic frequencies?
The Pharmacogenomics Journal2012Vol. 13(5), pp. 423–429
Citations Over TimeTop 18% of 2012 papers
Marie Loh, Delia Chua, Yuanhang Yao, Ross A. Soo, Kerryn L. Garrett, Nikolajs Zeps, Cameron Platell, Toshinari Minamoto, Koichi Kawakami, Barry Iacopetta, Richie Soong
Related Papers
- → Pharmacogenetic determinants of thiopurines in an Indian cohort(2020)8 cited
- → Allele and Genotype Frequencies of Cytochrome P450 2B6 516G>T Single Nucleotide Polymorphism in HIV-Negative and HIV-Infected Adult Nigerian Populations(2016)8 cited
- → Population genetic research of the mutation in ugt1a1 gene associated with reduced activity of liver UDP-glucuronosyltransferase A1(2020)2 cited
- → RENIN SINGLE-NUCLEOTIDE POLYMORPHISM (rs5705) IN HEALTHY INDIAN POPULATION(2018)1 cited
- → The simulation analysis on the population with a sole type of mating between different genotypes(2011)